Eton Pharmaceuticals, Inc. — All Filings
360 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-Q
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K/A | FORM 8-K/A | 0001437749-25-014334 | May 2, 2025 | Dec 19, 2024 |
| 8-K | FORM 8-K | 0001437749-25-013227 | Apr 28, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001437749-25-013137 | Apr 25, 2025 | Jun 10, 2025 |
| 8-K | FORM 8-K | 0001437749-25-010358 | Apr 1, 2025 | Mar 31, 2025 |
| 10-K | FORM 10-K | 0001437749-25-008136 | Mar 18, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-25-008137 | Mar 18, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-008163 | Mar 18, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-007615 | Mar 14, 2025 | — |
| 8-K/A | FORM 8-K/A | 0001437749-25-006678 | Mar 7, 2025 | Dec 19, 2024 |
| 8-K | FORM 8-K | 0001437749-25-005799 | Mar 3, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000163 | Feb 14, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-003070 | Feb 7, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-002935 | Feb 6, 2025 | — |
| 4 | FORM 4 - NR 01.06.25 2 | 0001437749-25-000466 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - JA 01.06.25 | 0001437749-25-000468 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - JG 01.06.25 | 0001437749-25-000452 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - SB 01.06.25 | 0001437749-25-000457 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - DK 01.06.25 | 0001437749-25-000455 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - NR 01.06.25 1 | 0001437749-25-000462 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - PM 01.06.25 | 0001437749-25-000459 | Jan 6, 2025 | Jan 3, 2025 |
| 4 | FORM 4 - CC 01.06.25 | 0001437749-25-000464 | Jan 6, 2025 | Jan 3, 2025 |
| 8-K | FORM 8-K | 0001437749-25-000109 | Jan 3, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-24-038020 | Dec 20, 2024 | Dec 19, 2024 |
| 8-K | FORM 8-K | 0001437749-24-037689 | Dec 17, 2024 | — |
| 424B5 | FORM 424B5 | 0001437749-24-037363 | Dec 12, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-037367 | Dec 12, 2024 | Dec 10, 2024 |
| SC 13G | — | 0000935836-24-000751 | Dec 9, 2024 | — |
| 3 | FORM 3 - IT 12.09.24 | 0001437749-24-037001 | Dec 9, 2024 | Dec 2, 2024 |
| 8-K | FORM 8-K | 0001437749-24-036504 | Dec 3, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-036095 | Nov 25, 2024 | Nov 22, 2024 |
| 10-Q | FORM 10-Q | 0001437749-24-034567 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001437749-24-034557 | Nov 12, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-033729 | Nov 7, 2024 | Nov 5, 2024 |
| 4 | — | 0001493152-24-042516 | Oct 25, 2024 | Oct 23, 2024 |
| 4 | — | 0001493152-24-040490 | Oct 8, 2024 | Oct 4, 2024 |
| 4 | FORM 4 - DK 10.04.24 | 0001437749-24-030714 | Oct 4, 2024 | Oct 2, 2024 |
| 8-K | FORM 8-K | 0001437749-24-030557 | Oct 3, 2024 | Oct 2, 2024 |
| 4 | — | 0001493152-24-036104 | Sep 12, 2024 | Sep 10, 2024 |
| SC 13G/A | — | 0001493152-24-036042 | Sep 12, 2024 | — |
| 3 | — | 0001493152-24-036039 | Sep 12, 2024 | Sep 9, 2024 |
| 8-K | FORM 8-K | 0001437749-24-025569 | Aug 8, 2024 | — |
| 10-Q | FORM 10-Q | 0001437749-24-025574 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K/A | FORM 8-K/A | 0001437749-24-024486 | Aug 2, 2024 | Jun 11, 2024 |
| 8-K | FORM 8-K | 0001437749-24-022736 | Jul 15, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-020967 | Jun 21, 2024 | Jun 14, 2024 |
| 8-K | FORM 8-K | 0001437749-24-019953 | Jun 11, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-015686 | May 9, 2024 | — |
| 10-Q | FORM 10-Q | 0001437749-24-015697 | May 9, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001437749-24-013838 | Apr 30, 2024 | — |
| DEF 14A | FORM DEF 14A | 0001437749-24-013429 | Apr 26, 2024 | Jun 11, 2024 |